Aspirin Versus Clopidogrel for Type 2 Diabetic Patients with First-Ever Noncardioembolic Acute Ischemic Stroke: Ten-Year Survival Data from the Athens Stroke Outcome Project
- PMID: 28756905
- DOI: 10.1016/j.jstrokecerebrovasdis.2017.06.052
Aspirin Versus Clopidogrel for Type 2 Diabetic Patients with First-Ever Noncardioembolic Acute Ischemic Stroke: Ten-Year Survival Data from the Athens Stroke Outcome Project
Abstract
Background and objective: Diabetes mellitus is associated with an increased risk of stroke and poor outcome following a stroke event. We assessed the impact of discharge treatment with aspirin versus clopidogrel on the 10-year survival of patients with type 2 diabetes after a first-ever noncardioembolic acute ischemic stroke (AIS).
Methods: This was a post hoc analysis of the Athens Stroke Outcome Project. Study outcomes included death, stroke recurrence, and a composite cardiovascular disease (CVD) end point (recurrent stroke, myocardial infarction, unstable angina, coronary revascularization, aortic aneurysm rupture, or sudden death). Kaplan-Meier survival curve and Cox regression analyses were performed.
Results: A total of 304 (93 women) diabetic patients receiving either aspirin (n = 197) or clopidogrel (n = 107) were studied. The 10-year survival was better in clopidogrel-treated patients than in aspirin-treated patients (19 deaths [17.7%] for clopidogrel versus 55 deaths [27.9%] for aspirin; log-rank test: 4.91, P = .027). Similarly, clopidogrel was associated with a favorable impact on recurrent stroke (12 events [11.2%] for clopidogrel versus 39 events [19.7%] for aspirin; log-rank test: 4.46, P = .035) and on the composite CVD end point (21 events [19.6%] for clopidogrel versus 54 events [27.4%] for aspirin; log-rank test: 4.17, P = .041). In the multivariable analysis, the beneficial effect of clopidogrel over aspirin on both primary and secondary end points was independent of age, gender, the presence of CVD or CVD risk factors, and stroke severity.
Conclusions: Our findings indicate a favorable effect of clopidogrel at discharge compared with aspirin in preventing death, recurrent stroke, and CVD events in diabetic patients with a first-ever noncardioembolic AIS.
Keywords: Aspirin; clopidogrel; diabetes; outcome; stroke.
Copyright © 2017 National Stroke Association. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Clopidogrel vs. aspirin treatment on admission improves 5-year survival after a first-ever acute ischemic stroke. data from the Athens Stroke Outcome Project.Arch Med Res. 2011 Aug;42(6):443-50. doi: 10.1016/j.arcmed.2011.09.001. Epub 2011 Sep 14. Arch Med Res. 2011. PMID: 21925223
-
Concomitant Use of Proton Pump Inhibitors and Clopidogrel Is Not Associated with Adverse Outcomes after Ischemic Stroke in Chinese Population.J Stroke Cerebrovasc Dis. 2016 Dec;25(12):2859-2867. doi: 10.1016/j.jstrokecerebrovasdis.2016.08.001. Epub 2016 Aug 18. J Stroke Cerebrovasc Dis. 2016. PMID: 27546731
-
Effect of Antiplatelet Therapy (Aspirin + Dipyridamole Versus Clopidogrel) on Mortality Outcome in Ischemic Stroke.Am J Cardiol. 2018 Sep 15;122(6):1085-1090. doi: 10.1016/j.amjcard.2018.05.043. Epub 2018 Jul 30. Am J Cardiol. 2018. PMID: 30072125
-
Benefits and Risks of Clopidogrel vs. Aspirin Monotherapy after Recent Ischemic Stroke: A Systematic Review and Meta-Analysis.Cardiovasc Ther. 2019 Dec 1;2019:1607181. doi: 10.1155/2019/1607181. eCollection 2019. Cardiovasc Ther. 2019. PMID: 31867054 Free PMC article.
-
Clopidogrel and aspirin after ischemic stroke or transient ischemic attack: an updated systematic review and meta-analysis of randomized clinical trials.J Thromb Thrombolysis. 2019 Feb;47(2):233-247. doi: 10.1007/s11239-018-1786-z. J Thromb Thrombolysis. 2019. PMID: 30511260
Cited by
-
The mechanisms and therapeutic potential of clopidogrel in mitigating diabetic cardiomyopathy in db/db mice.iScience. 2024 Feb 5;27(3):109134. doi: 10.1016/j.isci.2024.109134. eCollection 2024 Mar 15. iScience. 2024. PMID: 38375215 Free PMC article.
-
Clopidogrel Reduces Fibronectin Accumulation and Improves Diabetes-Induced Renal Fibrosis.Int J Biol Sci. 2019 Jan 1;15(1):239-252. doi: 10.7150/ijbs.29063. eCollection 2019. Int J Biol Sci. 2019. PMID: 30662363 Free PMC article.
-
Aspirin Versus Clopidogrel Monotherapy for the Secondary Prevention of Recurrent Cerebrovascular Attack Following Previous Ischemic Stroke in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.Diabetes Ther. 2020 May;11(5):1091-1101. doi: 10.1007/s13300-020-00801-5. Epub 2020 Mar 27. Diabetes Ther. 2020. PMID: 32221846 Free PMC article.
-
Impact of Lockdown Measures on Health Outcomes of Adults with Type 2 Diabetes Mellitus in Bangladesh.Healthcare (Basel). 2023 Apr 21;11(8):1191. doi: 10.3390/healthcare11081191. Healthcare (Basel). 2023. PMID: 37108025 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical